Status:

COMPLETED

Electroencephalography (EEG) Biomarkers of Response in Depression

Lead Sponsor:

University of California, Los Angeles

Collaborating Sponsors:

Medtronic - MITG

Wyeth is now a wholly owned subsidiary of Pfizer

Conditions:

Major Depressive Disorder

Eligibility:

All Genders

18-65 years

Phase:

PHASE4

Brief Summary

There are two specific aims of this project: 1. To identify physiologic indicators of venlafaxine treatment response using quantitative EEG (QEEG) cordance, and to determine if cordance changes are s...

Detailed Description

Our previous work indicates that a combination of neurophysiologic, symptom, and cognitive measures may predict response more accurately than brain functional measures alone. The purpose of this study...

Eligibility Criteria

Inclusion

  • All subjects will meet DSM-IV criteria for depression on the basis of a SCID-P interview, with subjects having a score on the 17-item Ham-D \> 17 (with item #1 \> 2).
  • Subjects will meet criteria both at recruitment and after a one-week single blind placebo wash-in. Study includes outpatients only.

Exclusion

  • All subjects will have no serious medical illness. The investigators will exclude patients also meeting criteria for the following groups of axis I diagnoses:
  • delirium or dementia
  • substance-related disorders
  • schizophrenia or other psychotic disorders, or eating disorders.
  • In addition, patients meeting criteria for cluster A or B axis II diagnoses will be excluded.
  • Subjects with a history of current or past active suicidal ideation, or suicide attempts will be excluded from the study.

Key Trial Info

Start Date :

November 1 2002

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2005

Estimated Enrollment :

44 Patients enrolled

Trial Details

Trial ID

NCT00759122

Start Date

November 1 2002

End Date

December 1 2005

Last Update

September 25 2008

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UCLA Laboratory of Brain, Behavior, and Pharmacology

Los Angeles, California, United States, 90024